The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis
Authors
Keywords
-
Journal
Journal of Cardiothoracic Surgery
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-19
DOI
10.1186/s13019-020-01390-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study
- (2018) Benedikt Haager et al. Journal of Thoracic Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†
- (2018) Marco Chiappetta et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach
- (2018) Weiye Deng et al. Journal of Thoracic Oncology
- Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
- (2017) Wenhua Liang et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer
- (2016) Masaya Tamura et al. World Journal of Surgical Oncology
- Lymph node ratio is a prognostic factor for non-small cell lung cancer
- (2015) Guangyuan Sun et al. Oncotarget
- Demonstration of the skip metastasis pathway for N2 non–small cell lung cancer
- (2014) Hiromitsu Takizawa et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Lymph Node Ratio Predicts Recurrence and Survival After R0 Resection for Non-Small Cell Lung Cancer
- (2013) Matthew D. Taylor et al. ANNALS OF THORACIC SURGERY
- Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer
- (2013) Raymond U. Osarogiagbon et al. ANNALS OF THORACIC SURGERY
- Prognostic Significance of the Extent of Lymph Node Involvement in Stage II-N1 Non-small Cell Lung Cancer
- (2013) Zi-Ming Li et al. CHEST
- Classifications of N2 Non–Small-Cell Lung Cancer Based on the Number and Rate of Metastatic Mediastinal Lymph Nodes
- (2013) Masaoki Ito et al. Clinical Lung Cancer
- Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer
- (2011) Sirisha Jonnalagadda et al. CANCER
- Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non–small-cell lung cancer
- (2010) Shin-ichi Yamashita et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer
- (2010) J. P. Wisnivesky et al. THORAX
- A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
- (2009) Emilio Bria et al. LUNG CANCER
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started